MasterPharm Recalls Formula 82M Due to Lack of Processing Controls
MasterPharm LLC is recalling 543 units of Formula 82M topical solution nationwide because the product lacks assurance of conformity to specifications.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation that may cause temporary or medically reversible adverse health consequences. The specific reason is a lack of processing controls, which is a quality assurance issue rather than a confirmed contamination or defect causing immediate harm.
Plain-English summary
MasterPharm LLC is recalling 543 units of Formula 82M (Minoxidil 5%/Tretinoin 0.01%/Fluocinolone acetonide 0.01%) in 0.5 FL OZ (15 mL) and 2 FL OZ (60 mL) bottles. The recall was initiated due to a lack of processing controls, which means there is a lack of assurance that the product conforms to its specifications.
The affected product was distributed nationwide in the United States. The recall covers specific production dates and expiration dates, including batches manufactured between January 13, 2020, and February 21, 2020, with expiration dates ranging from July 7, 2020, to August 16, 2020.
Consumers who have this product should stop using it and contact MasterPharm LLC at (866) 630-5600 for instructions on how to return the product or obtain a refund.
The recalled product
- Product
- Formula 82M (Minoxidil 5%/Tretinoin 0.01%/Fluocinolone acetonide 0.01%), a) 0.5 FL OZ (15 mL), b) 2 FL OZ (60 mL) bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600
- Manufacturer
- MasterPharm LLC
- Category
- Drug — Topical Solution
- Affected units
- 543
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- 01-17-2020:45@4
- 01-13-2020:40@27
- BUD 7/7/2020 01-21-2020:43@11
- BUD 7/18/2020 01-28-2020:88@15
- 01-31-2020:73@6
- BUD 7/26/2020 02-12-2020:43@16
- 02-17-2020:86@5
- BUD 8/10/2020 02-21-2020:23@1
- BUD 8/16/2020
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 26 recalled by MasterPharm LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 26 products in this recall →Related recalls
Same manufacturer · MasterPharm LLC
See all →- ModerateMasterPharm Recalls Tadalafil 12 mg Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Calcium Citrate Powder Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Testosterone/Anastrozole Pellets Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
Same hazard · lack of processing controls
See all →- ModerateMasterPharm Recalls Vardenafil Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Minoxidil/Biotin/Spironolactone Capsules Due to Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Yohimbine HCL Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
Similar recalls
- SevereMasterPharm Recalls Compounded Minoxidil, Biotin, and Spironolactone Capsules
FDA (Drugs) · 2020-07-08
- SevereMasterPharm Recalls Finasteride Plus Capsules Due to Minoxidil Contamination
FDA (Drugs) · 2020-05-20
- HighAcetaminophen Oral Solution Recalled for Manufacturing Process Control Failures
FDA (Drugs) · 2022-09-14
- ModerateAcetaminophen Oral Solution Recalled Due to Manufacturing Control Deviations
FDA (Drugs) · 2022-09-14
- SevereMIC+Methyl B12 Injection Recalled for Lack of Processing Controls
FDA (Drugs) · 2021-09-22
- ModerateLupin Recalls Fluocinolone Acetonide Topical Solution Due to Impurity Failures
FDA (Drugs) · 2018-10-31